High expressor paraoxonase PON1 gene promoter polymorphisms are associated with reduced risk of vascular disease in younger coronary patients (Q77753016)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 2002

Language	Label	Description	Also known as
English	High expressor paraoxonase PON1 gene promoter polymorphisms are associated with reduced risk of vascular disease in younger coronary patients	scientific article published on 01 April 2002

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

High expressor paraoxonase PON1 gene promoter polymorphisms are associated with reduced risk of vascular disease in younger coronary patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

vascular disease

1 reference

based on heuristic

inferred from title

author name string

Ilia Leviev

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Odette Poirier

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Viviane Nicaud

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Alun Evans

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Frank Kee

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Dominique Arveiler

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Caroline Morrisson

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

François Cambien

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Richard W James

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 April 2002

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Atherosclerosis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

161

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

463-467

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Low density lipoprotein oxidation and its pathobiological significance

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

The free radical theory of aging matures

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Mutations in the human paraoxonase 1 gene: frequencies, allelic linkages, and association with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900668-2

7 January 2021

Identifiers

10.1016/S0021-9150(01)00668-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888532%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77753016&oldid=1748087544"